Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium hyaluronate for subacromial impingement syndrome
NCT01735058Phase 3Unknown
- Start
- Feb 2012
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sodium hyaluronate in subacromial impingement syndrome (SAIS). Primary endpoint: Change from baseline in pain severity at 3 weeks. Status: unknown.
02
Drugs
sodium hyaluronate
03
Conditions
subacromial impingement syndrome (SAIS)
Beyond the preview
Go deeper on NCT01735058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01735058.